Lataa...
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer
PURPOSE: This study analyzed the role of plasma biomarkers for TSU-68 in a previous phase II trial comparing TSU-68 plus docetaxel and docetaxel alone in patients with metastatic breast cancer. MATERIALS AND METHODS: A total of 77 patients were eligible for this study (38 in the TSU-68 plus docetaxe...
Tallennettuna:
| Julkaisussa: | Cancer Res Treat |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Korean Cancer Association
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4843716/ https://ncbi.nlm.nih.gov/pubmed/26194374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2015.089 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|